Beijing Inflama Lab
PrivateLast Round
Series B
Jul 3, 2026
Total Funding Raised
$97.22M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Beijing Inflama Lab is a biotechnology company that develops revolutionary innovative drugs for the treatment of inflammation and tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Inflama Lab Comparables
Compare Beijing Inflama Lab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XtalPi | 78% | |
| DotBio | 77% | |
| Olatec Therapeutics | 73% |
Beijing Inflama Lab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 3, 2026 | ||||
| Series A Extension | May 24, 2024 | ||||
| Series A | Jul 10, 2023 | ||||
| Angel | Jan 1, 2021 |
Beijing Inflama Lab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Angel, Series A |
| Beijing Chang Development | Series B, Angel, Series A |
| MSA Capital | Series A, Angel |
| China Reform Holdings Corporation Ltd. | Series B |
| China Reform Fund Management Co.,Ltd | Series B |
| 上海国投先导私募基金管理有限公司 | Series B |
| Frees Fund | Series B, Series A Extension, Angel, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2026
Led by 上海国投先导私募基金管理有限公司 with participation from China Reform Fund Management Co.,Ltd.
Beijing Inflama Lab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beijing Inflama Lab's valuation, stock price, and market status.
Is Beijing Inflama Lab a public or private company?
Beijing Inflama Lab is a private company.
What is the current stock price of Beijing Inflama Lab?
Beijing Inflama Lab is a private company with no public stock price. No recent secondary market data is available.
How much is Beijing Inflama Lab worth (valuation)?
Valuation information for Beijing Inflama Lab is not publicly available.
Can I buy Beijing Inflama Lab stock?
Beijing Inflama Lab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beijing Inflama Lab's last funding round?
Funding round information for Beijing Inflama Lab is not publicly available.
Who are the main investors in Beijing Inflama Lab?
Investor information for Beijing Inflama Lab is not publicly disclosed.
Will Beijing Inflama Lab IPO soon?
No public IPO plans have been announced for Beijing Inflama Lab.
How can I track Beijing Inflama Lab secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing Inflama Lab's secondary market activity and sign up for updates.